News
After the slimming effect of Ozempic and Zepbound earned billions for Novo Nordisk and Eli Lilly, another class of ...
Zacks spotlights Alphabet, Bank of America, Roche, Village Super Market and Aware in fresh analyst reports highlighting key ...
Alphabet gains on AI-driven cloud, while YouTube and Google One push subscriptions past 270M despite litigation and cloud ...
Trans-Tasman drug developer Aft Pharmaceuticals is targeting lucrative niche diseases its Big Pharma rivals have ignored ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results